Cadisegliatin by VTv Therapeutics for Type 1 Diabetes (Juvenile Diabetes): Likelihood of Approval09/09/2024 majac Diabetes Cadisegliatin is under clinical development by vTv Therapeutics and currently in Phase III for Type 1 Diabetes (Juvenile Diabetes).Share on FacebookTweetFollow usSave